sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North American Neuromodulation Market Scope And Analysis

  • Report Code : TIPRE00016293
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 108
Buy Now

North American Neuromodulation Market Analysis Report 2020 to 2027

Buy Now

North American Neuromodulation Market Report North American Neuromodulation Market Size and Share North American Neuromodulation Market Scope and Analysis

North American Neuromodulation Market Report Scope

Report Attribute Details
Market size in 2019 US$ 3,029.72 Million
Market Size by 2027 US$ 6,612.00 Million
Global CAGR (2020 - 2027) 10.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Technology
  • External Neuromodulation
  • Internal Neuromodulation
By Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace Inc
  • NeuroSigma Inc
  • NEVRO CORP
  • Synapse Biomedical Inc
  • Soterix Medical Inc
  • Integer Holdings Corporation